Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...

The US Food and Drug Administration has granted breakthrough therapy designation to Oculis’ neuroprotective candidate ...

Please provide your email address to receive an email when new articles are posted on . A 57-year-old woman was transferred to Lahey Hospital and Medical Center emergency department from a community ...

A 27-year-old marketing professional was seen at Tufts Medical Center emergency department with new-onset vision changes in the right eye. She first noted a change in vision approximately 30 hours ...

One cause of a sudden loss of vision is referred to in medical terms as ischemic optic neuropathy. There are two types. One is caused by inflamed arteries in the eye that flow to the optic nerve, and ...

Optic neuritis is an inflammation of the optic nerve, a bundle of nerve fibers that relays visual information from the eye to the brain. The condition may cause vision disturbances that can resolve on ...

Erythropoietin (EPO), shown in early studies to potentially provide neuroprotection for patients with optic neuritis, failed to provide any significant neuroprotection in comparison with placebo in a ...

Oculis’ peptidomimetic small molecule has been shown to help protect the eyes of patients with inflammation of the optic nerve in a phase 2 study. The ACUITY trial in France analyzed 33 patients who ...

A 34 year-old woman presented with right facial numbness. She had left optic neuritis two years ago. Multiple Sclerosis (MS): Flair axial MRI images at the level of the medulla/cerebellum (left), and ...